Sequential Drug Delivery in Targeted Cancer Therapy

Abstract

Cancer is a major public health problem and one of the leading causes of death. However, traditional cancer therapy may damage normal cells and cause side effects. Many targeted drug delivery platforms have been developed to overcome the limitations of the free form of therapeutics and biological barriers. The commonly used cancer cell surface targets are CD44, matrix metalloproteinase-2, folate receptors, etc. Once the drug enters the cell, active delivery of the drug molecule to its final destination is still preferred. The subcellular targeting strategies include using glucocorticoid receptors for nuclear targeting, negative mitochondrial membrane potential and N-acetylgalactosaminyltransferase for Golgi apparatus targeting, etc. Therefore, the most effective way to deliver therapeutic agents is through a sequential drug delivery system that simultaneously achieves cellular- and subcellular-level targeting. The dual-targeting delivery holds great promise for improving therapeutic effects and overcoming drug resistance. This review classifies sequential drug delivery systems based on final targeted organelles. We summarize different targeting strategies and mechanisms and gave examples of each case.

Boosting Doxorubicin‐Induced Mitochondria Apoptosis for the Monodrug‐Mediated Combination of Chemotherapy and Chemodynamic Therapy

“…[ 8 ] However, free Dox prefers to gradually accumulate in nuclei rather than mitochondria and this biological tropism was even used for nuclear targeting. [ 9 ] In addition, the tumor microenvironment is extremely hypoxic and largely hampers the O 2 ‐dependent CDT pathway of Dox therapy. Moreover, tumor cells maintain the aberrant redox homeostasis featured with highly overexpressed glutathione (GSH).…”

The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy

“…For example, EVs, as noted above, lack an efficient and reproducible miRNA loading method. In addition, the enhanced permeability and retention effect worked in mouse models but not in humans, and an active targeting strategy is required to avoid the off-target effects [ 161 ]. Furthermore, the potential of immunogenicity is also a challenge in this field.…”

The Role of Molecular Imaging in Personalized Medicine

“…According to the World Health Organization, since cancer is positively correlated with patients’ ages, even if it affects younger people, cancer incidence prevalence and mortality are expected to significantly raise due to population growth and aging. This increases the importance of promoting and advancing health care systems and strategies and developing conventional therapy methods, including chemotherapy, radiation therapy, and surgery, to eliminate cancer cells, increase the survival rates of patients, and ensure sustainability, providing satisfactory global healthcare based on prevention, accurate diagnosis, and effective treatment that has less multi-drug resistance, high selectivity, and less cytotoxicity [ 4 , 5 , 6 ].…”

“…Conventional cancer therapy is non-targeting and damages healthy cells due to the accumulation of therapy on them, leading to the reduced efficiency of treatment. Therefore, it is desirable to develop targeted drug delivery systems that can deliver the therapeutic agent to the target tumor to reduce the adverse effects and improve efficacy [ 4 , 5 , 6 ].…”